ABBOTT LABORATORIES — Director's Dealing 2005

May 3, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-05-01

Reporting Person: Tyree James L (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-05-01	Common shares without par value	A	14100	$48.66	Acquired	66603	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-05-01	Option (right to buy)	$48.66	A	9667	Acquired	2015-04-30	common shares (9667)	Direct
2005-05-01	Option (right to buy)	$48.66	A	9667	Acquired	2015-04-30	common shares (9667)	Direct
2005-05-01	Option (right to buy)	$48.66	A	9666	Acquired	2015-04-30	common shares (9666)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1087	Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 29, 2005.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.